Gilead Sciences Inc (GILD)
65.41
+0.14
(+0.21%)
USD |
NASDAQ |
Apr 26, 16:00
65.41
0.00 (0.00%)
After-Hours: 19:01
Gilead Sciences Price to Book Value: 3.569 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 3.561 |
April 24, 2024 | 3.660 |
April 23, 2024 | 3.657 |
April 22, 2024 | 3.653 |
April 19, 2024 | 3.642 |
April 18, 2024 | 3.610 |
April 17, 2024 | 3.652 |
April 16, 2024 | 3.672 |
April 15, 2024 | 3.696 |
April 12, 2024 | 3.714 |
April 11, 2024 | 3.746 |
April 10, 2024 | 3.717 |
April 09, 2024 | 3.816 |
April 08, 2024 | 3.788 |
April 05, 2024 | 3.796 |
April 04, 2024 | 3.795 |
April 03, 2024 | 3.868 |
April 02, 2024 | 3.933 |
April 01, 2024 | 3.976 |
March 28, 2024 | 3.996 |
March 27, 2024 | 3.983 |
March 26, 2024 | 3.951 |
March 25, 2024 | 3.96 |
March 22, 2024 | 3.962 |
March 21, 2024 | 3.988 |
Date | Value |
---|---|
March 20, 2024 | 4.036 |
March 19, 2024 | 4.005 |
March 18, 2024 | 3.997 |
March 15, 2024 | 4.020 |
March 14, 2024 | 4.049 |
March 13, 2024 | 4.143 |
March 12, 2024 | 4.096 |
March 11, 2024 | 4.110 |
March 08, 2024 | 4.099 |
March 07, 2024 | 4.019 |
March 06, 2024 | 3.963 |
March 05, 2024 | 3.982 |
March 04, 2024 | 3.942 |
March 01, 2024 | 3.945 |
February 29, 2024 | 3.934 |
February 28, 2024 | 3.966 |
February 27, 2024 | 3.984 |
February 26, 2024 | 3.980 |
February 23, 2024 | 4.013 |
February 22, 2024 | 3.971 |
February 21, 2024 | 3.994 |
February 20, 2024 | 3.930 |
February 16, 2024 | 3.905 |
February 15, 2024 | 4.004 |
February 14, 2024 | 3.986 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.446
Minimum
Mar 10 2022
5.431
Maximum
Jul 20 2020
4.259
Average
4.277
Median
Price to Book Value Benchmarks
Amgen Inc | 23.22 |
Johnson & Johnson | 5.106 |
Eli Lilly and Co | 64.73 |
Pfizer Inc | 1.610 |
CymaBay Therapeutics Inc (DELISTED) | 12.76 |
Price to Book Value Related Metrics
PE Ratio | 14.54 |
PS Ratio | 3.034 |
PEG Ratio | 0.6241 |
Price to Free Cash Flow | 11.09 |
Price | 65.41 |
Earnings Yield | 6.88% |
Market Cap | 81.49B |
PEGY Ratio | 0.5207 |
Operating PE Ratio | 9.341 |
Normalized PE Ratio | 12.46 |